Stay updated with breaking news from Laman Gray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The story of the first woman to receive an Aeson, an investigational, implantable artificial heart, prompted this cardiologist to reflect on the low use of bridging devices and heart transplants in women.
A cardiothoracic surgical team with UofL Health – Jewish Hospital and the University of Louisville has performed the world's first Aeson® bioprosthetic total artificial heart implantation in a female patient. The investigational device, currently intended as a bridge to heart transplant, is part of an Early Feasibility Study (EFS) sponsored by CARMAT, a French medical device company, in partnership with UofL, UofL Health – Jewish Hospital and the UofL Health – Trager Transplant Center.